| Ticker: | ATNM |
| Current Price: | $0.97 |
| % Daily Change: | -2.49% |
| Volume (1,000s): | 84.63 |
| Average Volume (1,000s): | 118.44 |
| Market Cap (M): | $30.58 |
| 1/2/2024 Price: | $5.32 |
| Change Since Inception: | -81.77% |
Actinium Pharmaceuticals, Inc.
275 Madison Avenue
7th Floor
New York, NY 10016
United States
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT